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Abstract
Diets rich in omega-3s have been thought to prevent both obesity and osteoporosis. However, 
conflicting findings are reported, probably as a result of gene by nutritional interactions. 
Peroxisome proliferator-activated receptor-gamma (PPARγ), is a nuclear receptor that improves 
insulin sensitivity but causes weight gain and bone loss. Fish oil is a natural agonist for PPARγ 
and thus may exert its actions through PPARγ pathway. We examined the role of PPARγ in body 
composition changes induced by a fish or safflower oil diet using two strains of C57BL6J (B6); 
i.e. B6.C3H-6T (6T) congenic mice created by backcrossing a small locus on Chr 6 from C3H 
carrying ‘gain of function’ polymorphisms in the Pparγ gene onto a B6 background, and C57BL6J 
mice. After 9 months of feeding both diets to female mice, body weight, percent fat and leptin 
levels were less in mice fed the fish oil vs those fed safflower oil, independent of genotype. At the 
skeletal level, fish oil preserved vertebral bone mineral density (BMD) and microstructure in B6 
but not in 6T mice. Moreover, fish oil consumption was associated with an increase in bone 
marrow adiposity and a decrease in BMD, cortical thickness, ultimate force and plastic energy in 
femur of the 6T but not B6 mice. These effects paralleled an increase in adipogenic inflammatory 
and resorption markers in 6T but not B6. Thus, compared to safflower oil, fish oil (high ratio 
omega-3/-6) prevents weight gain, bone loss, and changes in trabecular microarchitecture in the 
spine with age. These beneficial effects are absent in mice with polymorphisms in the Pparγ gene 
(6T), supporting the tenet that the actions of n-3 fatty acids on bone microstructure are likely to be 
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genotype dependent. Thus caution must be used in interpreting dietary intervention trials with 
skeletal endpoints in mice and in humans.
Keywords
aging; Omega-3s; Bone-fat interactions; Genetic animal models; bone microCT
Introduction
The loss of bone mineral density (BMD) and the increase in bone marrow adiposity are 
common hallmarks of the aging process (1). As the average life expectancy continues to 
increase, the need to develop new strategies to prevent osteoporosis and fragility fractures is 
rising. Dietary factors have long been known to influence bone remodelling and fragility (2). 
Several epidemiological studies have particularly focused on Mediterranean diets (3,4) and 
have suggested an association between fish oil consumption and lower rate of bone loss in 
older adults (5–7). However, conflicting results are reported in clinical and pre-clinical 
studies. For example, in epidemiological studies, BMD was positively associated to n-3 
polyunsaturated fatty acids (PUFA) (8) or fish (9,10) consumption. Cross sectional studies 
also reported a lower risk of osteoporosis fracture among women with a higher intake of sea 
food (11). In contrast, others found no significant association between PUFA consumption, 
bone formation markers, BMD or risk fracture (12,13,14). Moreover, other studies highlight 
opposite findings by showing a higher fracture risk in women taking higher polyunsaturated 
fat (15). Although those discrepancies may arise due to various confounding factors (age, 
dose, time of treatment…), one of the main explanations might relate to the interaction 
between dietary intake and the genome, since genetic factors are thought to contribute 
between 55% to 85% to the variance of bone loss with age (16).
B6.C3H-6T congenic (6T) mice were developed to gain insights into the genetics and 
biology underlying phenotypes of the C3H/HeJ (C3H, High BMD and IGF-1) and the 
C57BL/6J (B6, low BMD and IGF-1) mice. 6T mice were generated by intercrossing a 
region of Chromosome 6 from C3H onto a B6 background and then backcrossing 10 
generations onto B6. The Chromosome 6 quantitative trait locus (QTL) encompasses close 
to 20cM on mid-distal mouse chromosome 6; there are more than 500 genes in this region; 
however, finer mapping revealed a list of 21 candidate genes; of those there are hundreds of 
SNPs between C3H and B6; however there are only 3 coding non synonymous SNPs, none 
of which differed between C3H and B6 (17). Based on previous studies, 2 SNPs located in 
the distal UTR of PPARγ were identified to be the most important contributor to the 6T 
phenotype and both these were associated with a gain of function of PPARγ. In previous 
work, low bone mass and reduced IGF-1 (systemic and locally) were the major phenotypic 
characteristics of the 6T mouse; both these were worsened by feeding a high fat diet due to 
the increased activity of PPARγ (18). This supported the possibility that PPARγ itself was 
one of the determinants of Igf-1 gene expression and protein level (19). Nocturnin, a 
circadian deadenylase was found to be markedly enhanced when PPARG was activated, and 
this in turn was thought to cause the low skeletal and circulating IGF-1 levels (20). 
Association between bone and PPARγ was verified in a human cohort, showing different 
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skeletal responses to dietary environment depending on the genetic variation of Pparγ (18, 
21).
Other genetic mouse models support the notion that enhanced PPARγ signalling worsens 
bone health with age. PPARγ regulates osteoclastogenesis directly through C-fos expression 
(22) and indirectly by decreasing the OPG/RANKL ratio in osteoblast/osteocytes (23, 24). 
As such PPARγ activation may have several effects on bone, including increased bone 
marrow adiposity, decreased osteoblastogenesis and increased osteoclastogenesis (20, 22, 
23).
In vitro, fish oil has been shown to directly up-regulate PPARγ in different cell lines such as 
C2C12 myocyte or HEK293T kidney cells (25, 26, 27); however in vivo fish oil decreased 
the absolute amount of PPARγ by decreasing peripheral fat. In rodents, fish oil 
supplementation has been shown to reduce fat mass and to improve BMD in aging mice 
after 4 and 6 months of supplementation respectively in Balb/c and C57BL6J mice (28, 29). 
However, our groups and others reported also in C57BL6J mice either a modest or no 
structural and mechanical effect on bone of the n-3 fatty acids (FA), respectively after 5 and 
14 months of supplementation, mainly found in fish oil (30).
We therefore postulated that the conflicting results of fish oils on bone health with aging 
may result from a gene×diet interaction between fish oil intake and Pparγ genotype. In this 
study we used the 6T congenic mice to investigate independent and interactive effects of 
fish oil with Pparγ genotypes on bone mass, structure and strength in female mice aged 
from 3 to 12 months old.
Materials and methods
Animals
Forty 10 weeks-old female B6.C3H-6T (6T, n=20) and C57BL/6J (B6J, n=20) mice were 
obtained from the Jackson laboratory (Bar Harbor, ME, USA). The B6.C3H-6T congenic 
strain was made as previously described (17, 18). Weight-matched mice were housed in a 
laboratory animal care facility in cages (5 mice/cage) and fed a standard pellet diet for 2 
weeks. At 12 weeks of age, B6.C3H-6T and C57BL/6J mice were divided into two dietary 
groups (n = 10 per group) and fed 22% safflower oil or 22% fish oil diets (Harlan Teklad 
TD.08324 and TD08323, supplemental table S1–S2). Isocaloric diets were ensured by 
Harlan. The two diets were constituted by weight of pellet 21.2% of protein, 42.3% of 
carbohydrate and 22.2% of fat. Animals were pair feed. Food consumption was recorded 
weekly in 6T safflower oil, 6T fish oil, B6 safflower oil or B6 fish oil groups and the 
smallest amount of food intake observed was then fed to all the 4 groups over the following 
week. Supplements were freshly prepared every three months, stored in aliquots at 4°C and 
distributed every 2 or 3 days. Mice were maintained on a 12-h light/dark cycle at an ambient 
temperature of 22–25°C. All mice were sacrificed at the age of 12 months consider to be old 
mice. Animal procedures were approved by the University Of Geneva School Of Medicine 
Ethical Committee and the State of Geneva Veterinarian Office.
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In vivo measurement of bone mineral density and body composition
Total body mass, lean body mass, fat mass, femoral and spinal bone mineral density (BMD, 
g/cm2) were measured in vivo at baseline and just before euthanasia by dual-energy X-ray 
absorptiometry (PIXImus2, GE lunar, Madison WI) (31).
In vivo measurement of morphology and microarchitecture
A high-resolution in vivo microcomputed tomography system (microCT Skyscan 1076, 
Skyscan, Aartselaar, Belgium) was used to scan the left tibia and the caudal vertebrae at 3 
and 12 months of age. The in vivo microCT system consists of an X-ray source and detector 
rotating around the animal bed. The microCT machine is equipped with a 100 Kv X-ray 
source with a spot size of 5 µm. A scan lasted approximately 20 min, resulting in shadow 
projections with a pixel size of 12 µm. A modified Feldkamp algorithm, using 
undersampling to reduce noise, was applied to the scan data, resulting in reconstructed 3D 
data sets with a voxel size of 20 µm (32). A detailed description and validation of the 
algorithm is published elsewhere (33). Cortical and trabecular bones were separated 
manually with “CT analyzer” software. Outcomes measure for the trabecular and cortical 
structure are described by Bouxsein et al. (34). To evaluate bone marrow adiposity tibias, we 
processed ex-vivo protocol with osmium staining as described (35). After labeling of lipids 
by osmium tetroxide, the bones were imaged using energy of 45 keV (UCT40, Scanco 
Medical AG, Basserdorf Switzerland).
Histomorphometry
Femur and lumbar spine L5 were embedded in methyl-methacrylate (Merck, Darmstadt, 
Germany) as previously described (36). Five-8µm thick sagital sections were cut with a 
Leica Corp. Polycut E microtome (Leica Corp. Microsystems AG, Glattburg, Switzerland) 
and stained with modified Goldner’s trichrome, and histomorphometric measurements were 
performed on the secondary spongiosa of the distal femur metaphysis and vertebral body of 
L5, using a Leica Corp. Q image analyser at 40X magnification. Two sections for each 
stained sample were quantified per animal. TRAP was detected by using hexazotized 
pararosanilin (Sigma, St Louis, MO) and naphtol ASTR phosphate (Sigma, St Louis, MO) to 
reveal osteoclasts, ; non-osteoclastic acid phosphatase was inhibited by adding 100mMol/L 
L(+)-tartric acid (Sigma, St Louis, MO) to the substrate solution. The following parameters 
were recorded: the number of TRAP+ osteoclasts in contact with trabeculae (N.Oc/TBPm ; 
expressed in cells per millimeter of trabecular bone surface) ; the resorption surface (OcS/
BS ; expressed in %) ; the average length of the zone of contact per osteoclast (Oc.Pm/
N.Oc ; given in microns).
Testing of mechanical resistance
The night before mechanical testing, bones were thawed slowly at 7°C and then maintained 
at room temperature. Femur was placed on the material testing machine on two supports 
separated by a distance of 9.9 mm and load was applied to the midpoint of the shaft, thus 
creating a three-point bending test. The mechanical resistance to failure was tested using a 
servo-controlled electromechanical system (Instron 1114, Instron corp., High Wycombe, 
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UK) with actuator displaced at 2mm/minute. Outcomes measures were ultimate force, 
stiffness, and energy as described by Turner and Burr (37).
RNA extraction and Quantitative PCR. Bone
The whole tibia was excised and immediately pulverized to a fine powder in peqGold Trifast 
(peQLab Biotechnologie GmbH) using FastPrep System tube and appartus (QBiogene, 
Illkirch, France) in order to achieve quantitative RNA extraction. We used a lysis time and 
speed respectively of 14sec and 5 m/s, as recommended by the maker. Total RNA extraction 
and quantitative PCR were performed as previously described (36). The following pre-
designed TaqMan® gene expression assays were used for the quantitative RT-PCR 
(References, Gapdh: Mm00437762_m1, Igf-1: Mm00439559_m1, Il-6: Mm00446190_m1, 
Rankl: Mm00441908_m1, Opg: Mm00435452_m1, Fabp4: Mm00445878_m1, AdipoQ: 
Mm01343606_m1, Adipsin: Mm00439559_m1, Mcsf: Mm00432689_m1, Il1-ra: 
Mm00446185, Tnfα: Mm99999068_m1, Trap: Mm00475698_m1, Fsp27: 
Mm00617672_m1, Lpl: Mm00434764_m1, Pepck: Mm00440635_m1, Pparγ: 
Mm01184322_m1 Applied Biosystems, Rotkreuz, Switzerland) consisting of two unlabeled 
primers and a FAM™ dye-labeled TaqMan® MGB probe, and the correspondent buffer 
TaqMan® Universal PCR Master Mix (Applied Biosystems, Rotkreuz, Switzerland). 
Relative quantities (RQ) were calculated with the formula RQ=E-Ct using an efficiency (E) 
of 2 by default. The mean quantity was calculated from triplicates for each sample and this 
quantity was normalized to the similarly measured mean quantity of the GAPDH 
normalization gene. Finally, normalized quantities were averaged for 3 to 4 animals and 
represented as mean ± SEM.
White adipose tissue (WAT)
Total RNA from peri-ovarian WAT was extracted using the Trizol reagent (Life 
technologies, Zug, Switzerland) to the manufacturer’s protocol. Three micrograms total 
RNA were reverse-transcribed using 400 units of Moloney Murine Leukemia Virus 
(MMLV) Reverse Transcriptase (Invitrogen, Basel, Switzerland), in the presence of 1 unit/µl 
RNAsin (Promega Corp, Madison, WI, USA), 0.2 µg random primers (oligo(dN)6) 
(Promega Corp, Madison, WI, USA), 2 mM dNTP and 20 µM DTT (Invitrogen, Basel, 
Switzerland). The expression of the cDNAs was determined by quantitative real-time PCR 
using an ABI step one plus sequence detection System (Applera Europe, Rotkreuz, 
Switzerland) and were normalized using the housekeeping genes Ribosomal Protein S29. 
PCR products were quantified using the Power Master SYBR Green mix (Applera Europe, 
Rotkreuz, Switzerland) and results are expressed in arbitrary units (A.U) relative to the 
control group mean value. Primers sets were designed using the Primer Express software 
(Applera Europe, Rotkreuz, Switzerland) and were chosen when possible on both sides of an 
intron to avoid amplification of possible contaminating genomic DNA. The annealing 
temperature (60°C) and amplicon size (50–150 bp) were automatically determined by the 
software. Oligos were used at 217nM each (Microsynth, Switzerland). The sequence of the 
primers used is provided in supplemental table S3.
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Collection of serum
Blood from all mice was obtained by retro-orbital collection at baseline and after 6 and 14 
months of diets. After centrifugation, serum was removed and stored at −80°C until analysis. 
Serum TRACP5b (tartrate-resistant alkaline phosphatise form 5b) and osteocalcin were 
measured according to manufacturer’s instructions (SB-TR103 SBA Sciences, Turku, 
Finland; and CN50-1300 Biomedical Technologies Inc., Stoughton, MA, USA, 
respectively). IGF-I (AC-18F1 Immunodiagnostic Systems, Paris, France), myostatin 
(9875-11 US biological life science, Salem, MA01970) and leptin (90030 Crystal Chem Inc, 
Downers Grove, IL 60515) were measured in serum by immunoenzymometric assay 
(IEMA) with a kit from IDS following the manufacturer’s instructions.
Data analysis
We tested the significance of diet effects by a two way ANOVA repeat measurements with 
the type of diet and genotype as factors. As appropriate, post hoc testing was performed 
using Fisher’s protected Least Squares Difference (PLSD). The p of interaction between the 
diet and genotype was only mentioned when significant. Differences were considered 
significant at p < 0.05. Data are presented as mean ± SEM.
Results
Effect of n-3/n-6 FAs ratio on body composition and gene expression of WAT in B6 and 6T
Overall, no significant differences in food intake were observed between groups (Fig. S1). 
At baseline, 6T tend to have a lower body weight, % fat mass and a higher % lean than B6. 
There are no significant differences in appendicular lean mass (Table S4). After 9 months of 
supplementation, the fish oil diet resulted in decreased body weight and % fat mass whereas 
it led to an increase in the %lean vs the safflower oil. These effects were similar in 6T and 
B6 (Fig. 1A–C). Interestingly, appendicular lean mass gain was lower in 6T than in B6 
(+0.068±0.04% vs +0.162±0.05%, p<0.05) but was not influenced by fish oil. At sacrifice, 
WAT (peri-ovarian and peri-kidney) and BAT mass per kg of body weight significantly 
decreased with fish oil vs safflower oil diet in both 6T and B6 (Fig. 1D–E). Interestingly, the 
fish oil diet led to a more drastic reduction in WAT (around 54%) than BAT (around 20%) 
in both 6T and B6 (Fig. 1D–F).
In B6 mice, gene expression analysis of peri-ovarian WAT indicated that fish oil 
significantly decreased the markers of adipogenesis (leptin, adiponectin, Fas) and increased 
Pparβ (+158% vs safflower oil, p<0.05) (Table 1). In contrast, fish oil did not have any 
significant effect on leptin, adiponectin and Pparβ expression in 6T; rather it increased the 
expression of inflammatory markers Fas and Tnfα (respectively, +87% and +51% vs 
safflower, p<0.05).
Effect of n-3/n-6 FAs ratio on BMD and trabecular microarchitecture in B6 and 6T
At baseline, 6T mice exhibited lower total body BMD and trabecular bone volume at the 
lumbar spine compared to B6 mice (Table S4). In B6 mice, fish oil significantly increased 
lumbar spine BMD vs safflower oil whereas it did not have any impact on total body and 
femoral BMD. In contrast, in 6T mice, fish oil did not have significant effect on lumbar 
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spine BMD but significantly decreased the total body and femoral BMD vs safflower oil 
(Fig. 2 A–C). Age-related changes in trabecular microarchitecture followed a similar pattern 
in the proximal tibia and caudal vertebrae; although in the tibia the loss of BV/TV and TbN 
was more dramatic (Fig. 2 D–I). At the vertebrae, fish oil significantly prevented the 
decrease of BV/TV and Tb.N with age in B6 mice. The same trend was observed in 6T mice 
but the difference was not significant (Fig. 2 D–F). At the proximal tibia, fish oil did not 
have any significant effect in B6, whereas in 6T mice, it significantly accentuated the loss of 
bone volume fraction and trabecular number with age (Fig. 2 G–I). In addition, 6T mice on a 
fish oil diet had increased bone marrow adiposity vs B6 mice on a long term fish oil diet 
(MicroCT AdV/TV, 0.12±0.05 vs 0.02±0.005, respectively, p<0.05).
Effect of n-3/n-6 FAs ratio on cortical architecture and mechanical properties in B6 and 6T
At baseline, 6T mice exhibited lower cortical tissue and bone volume at the mid tibia 
compared to B6 mice (Table S4). Cortical architecture evolution at the mid-tibia diaphysis is 
shown in figure 3. Gain in Cortical Bone volume (CtBV) between 3 and 12 months of age is 
lower in fish oil group’s vs safflower oil either in B6 and 6T mice. However, this effect 
disappears after adjustment by body weight. Tissue volume (TV) increased equally from 3 
to 12 months of age in all groups (around 18%), consistent with a continuous periosteal bone 
apposition. In B6 mice, bone marrow volume increased with age in a similar manner to fish 
and safflower oil (around 25%), therefore CtTh decreased equally in the two groups. In 6T, 
the bone marrow volume increase was higher in fish vs safflower oil; hence fish oil 
decreased CtTh more than safflower oil (Fig. 3A–E). As a result, in B6 mice fish oil did not 
significantly change ultimate force, stiffness, elastic, plastic and fracture energy. In contrast, 
in 6T mice, fish oil significantly decreased ultimate force, yield point, elastic, plastic and 
fracture energy (Fig. 4A–F). In sum when mice are fed with fish oil, 6T has lower ultimate 
force, plastic and fracture energy, −17.2%, −27.2% and −21.2% vs B6 respectively, all 
p<0.05.
Effect of n-3/n-6 FAs ratio on osteoclast number and bone marrow adiposity in B6 and 6T
In B6 mice, osteoclast surface and adipocyte volume in femur did not differ between fish 
and safflower oil (Fig. 5A&H). In lumbar spine, osteoclast surfaces and numbers were 
significantly decreased with the fish oil diet vs safflower oil and adipocytes were not 
detectable (Fig. 5D–F). In 6T, fish oil increased osteoclastic and adipocyte number, 
qualitatively by histmorphometry and quantitatively by microCT with osmium, vs safflower 
oil in femur whereas it had no significant effect in lumbar spine (Fig. 5G–I). Thus 6T mice 
fed with fish oil have higher osteoclast surface and numbers, as well as more marrow 
adiposity compared to B6.
Effect of n-3/n-6 FAs ratio on bone markers in B6 and 6T
At baseline, 6T mice tend to exhibit lower leptin and IGF-1 levels compared to B6 mice 
(table S4) similar to what has been reported previously (17). Levels of osteocalcin and 
TRAP5b were not significantly different between the congenic and B6 mice. In B6, 
osteocalcin levels decreased less with age in fish oil vs safflower oil diet and TRAP5b 
remained unchanged between groups. In contrast, in 6T mice, fish oil did not slow the 
osteocalcin decrease with age and tended to increased TRAP5b (Table S5). In accordance 
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with WAT mass changes, the increase of leptin with age was lower in mice fed the fish oil 
vs those fed the safflower oil in both 6T and B6 mice (Table S5).
Effect of n-3/n-6 FAs ratio on gene expression of the tibia in B6 and 6T
In order to clarify the molecular mechanisms by which fish oil mediates different skeletal 
responses to aging between B6 and 6T, we next examined gene expression in the tibia of 
both strains. In B6 mice, fish oil decreased markers of bone resorption (Mcsf, Trap) and 
elicited an anti-inflammatory effect as indicated by an increase in Il1-ra and a decrease in 
Tnfα vs safflower oil (+199% and −18% respectively, p<0.001). Fish oil also decreased 
Pparγ (−43% vs safflower, p<0.01), i.e. markers of adipogenesis (Table 2).
In 6T mice, fish oil decreased Pparγ expression (−21% vs safflower, p<0.01), however this 
decrease was lower than observed in B6. Interestingly, the fish oil diet in 6T increased 
others adipogenic markers such as adiponectin +33%, Fsp27 +59% and Pepck +358% vs 
safflower oil (i.e an important indicator of gain of function in PPARγ), all p<0.05; as well as 
markers of inflammation (Tnfα: +28% vs safflower, p<0.01). Moreover, markers of bone 
resorption such as Mcsf and Trap remained unchanged in response to fish oil (Table 2).
Discussion
The mains goal of our study was to elucidate the role of genetic background on the skeletal 
response to n-3 PUFA. As omega-3 fatty acid is a known ligand for PPARγ (38, 39), we 
challenged mice with a fish oil diet, utilizing the very modest genotypic differences between 
the 6T congenic mouse and B6. The 30 cM QTL on mouse Chr 6 that originated from 
C3H/HeJ and was backcrossed onto B6 includes the Pparγ gene which exhibits a gain of 
function, due to polymorphisms in the 3’ UTR. Previously these mice were characterized by 
their high marrow adiposity, low bone mass and reduced circulating IGF-I (40). In the 
current report, we found that fish oil intake, rich in omega n-3 FA, was associated with an 
increase in BMD and trabecular microarchitecture at the caudal vertebrae in B6 mice, 
mainly due to a decrease in osteoclast number through a decrease in inflammatory 
cytokines. However, fish oil did not significantly improve bone mechanical properties. In 
6T, fish oil did not decrease the osteoclast number and surfaces and did not prevent 
trabecular bone loss with age. This suggests that, when PPARγ activity is initially increased, 
i.e. as in 6T bone, fish oil was unable to reduce its activity enough to prevent trabecular 
bone loss with age. Moreover, in 6T, fish oil reduces mechanical properties, i.e. ultimate 
force and plastic energy, associated with a decrease in cortical thickness and an increase in 
bone marrow volume. Therefore, these findings offer a potential explanation for the 
inconsistent effects of omega-3 fatty acid supplementation on the murine skeleton and may 
provide insight into the heterogeneity in the skeletal response to specific diets in humans.
In accordance with previous experiments, we confirmed that 6T mice had a low vertebral 
trabecular bone fraction, cortical bone microarchitecture with an increase in bone marrow 
adiposity and Pparγ expression in bone (41). We also confirmed lower bone marrow 
adipocytic density in the lumbar spine compared to the femur, similar to what has been 
reported in humans (42). Moreover we found that 6T did not exhibit more brown or brown 
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like fat, nor more leptin, but did have more osteoclasts, indicating that increased PPARγ 
activity in bone may directly increase osteoclast numbers (22).
In B6 mice, the fish oil diet significantly reduced the body weight and fat mass gain with 
age; at sacrifice the fish oil group had lower WAT and BAT mass, with a marked decrease 
in circulating leptin levels. Interestingly, the decrease of WAT was 3 fold higher than the 
decrease of BAT, suggesting that fish oil decreased fat mass but preserved a beneficial 
metabolic profile (43). The pattern of gene expression in white fat indicated a reduction of 
adipogenesis (leptin, adiponectin, Fas) and an increase of FA oxidation through Pparβ but 
without changes in Pparγ (44). At the bone tissue levels fish oil significantly decreased 
Pparγ and increased Igf-1 gene expression while it preserved vertebral BMD and cancellous 
bone volume supporting the observations that PPARγ regulates IGF-I, probably through 
indirect mechanisms (19). Surprisingly, fish oil did not affect the other determinants of 
adipogenesis such as Adiponectin, Adipsin, Fsp27 and Pepck, and as a result bone marrow 
adiposity was not significantly altered by fish oil in our model. In accordance with Sun et al 
(28), the fish oil bone effect could be mediated by inflammatory cytokines (TNFα, IL1-Ra). 
As we previously demonstrated in C57BL6J mice, long-term supplementation of omega-3 
FA also may exert these positive effects by decreasing leptin (45). Indeed, 
intracerebroventricular leptin injection has been shown to induce trabecular bone 
remodelling in vertebrae by triggering β-adrenergic signalling in the CNS, which in turn 
increases osteoclast number and activity (46, 47). However, this decrease in osteoclasts had 
little influence on femoral BMD, cortical thickness or the mechanical properties.
In 6T mice, fish oil diet decreased body weight, fat gain, and circulating leptin in a similar 
manner to B6 mice. However, markers of adipogenesis that were decreased in B6 in 
response to fish oil were unchanged in 6T mice. Fish oil can modulate body fat 
metabolically by increasing lipolysis and fatty acid oxidation (48); or by reducing food 
intake through the endocannabinoid and mesocorticolimbic dopamine system (49). This 
second mechanism was not operative in our experiments due to the use of isocaloric diet and 
pair feeding. So these data suggest that the difference in adipogenesis markers at the gene 
expression levels were not translated into differences in fat mass gain. At the bone levels, 6T 
mice exhibited resistance to the positive effect of fish oil on cancellous bone. Moreover, fish 
oil consumption was associated with a further increase in bone marrow adiposity and a 
decrease in BMD, cortical thickness and finally femoral mechanical properties. These 
negative effects paralleled an increase in resorption, adipogenic and inflammatory markers 
including adiponectin, probably because 6T mice have a gain of function in the Pparγ gene 
compared to B6 mice. The interaction between omega-3 FA effect and level of PPARγ 
activation has also been found pharmacologically in skeletal muscle where inhibition of 
PPARγ, prevented the action of n-3 fatty acid on cell differentiation (50). Pparγ is likely not 
the only gene that contributes to the skeletal phenotype of the 6T congenic strain since 
Cidea, Zfp422 and Alox5 genes are within the QTL and could be potential candidates to 
explain both the bone marrow fat and skeletal response to fish oil diet, although these genes 
do not have functional polymorphisms between C3H and B6 (51).
There are several limitations to our study. First, the 6T congenic mouse has polymorphic 
differences in multiple genes that could impact the skeletal response to dietary interventions 
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relative to B6. In particular, this QTL contains other genes that may impact fat mass such as 
Cidec, a mediator of apoptosis in adipocytes. Notwithstanding, congenic rather than pure 
inbred mice, are more representative of the heterogeneity in the genetic background of most 
mammals. Hence our conclusions about diet×gene interactions are not inconsistent with 
larger cohort studies in humans. Second, Pparγ gene expression does not equate with its 
nuclear receptor activity. Hence relative differences in Pparγ gene expression by strain may 
not reflect in vivo activities. Indeed, marrow adiposity was increased in 6T in response to 
the fish oil diet despite a modest reduction in gene expression. Third, our studies only lasted 
nine months; hence the long term effects of diet on bone and body composition, particularly 
in older individuals may be affected by age related changes in several genes including 
Pparγ. In conclusions, our observations confirm that long-term fish oil diet rich in omega-3 
FAs could have a favourable impact on fat mass, skeletal integrity and bone loss with age, 
i.e bone mass and trabecular bone microarchitecture in vertebrae(52). However, at the 
skeletal level, the beneficial effects of a fish oil diet may be dependent on the presence of 
allelic variants in several genes, including Pparγ. Therefore, our findings emphasize the 
need to consider nutrient by genotype interactions when considering the beneficial or 
harmful effects of a particular diet.
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Highlights
- Fish oil reduced body weight and fat mass gain with age in B6 mice
- In B6, fish oil preserved vertebral BMD and cancellous bone by a decrease in 
osteoclast
- 6T mice exhibit resistance to fish oil effect on bone due to a gain of function 
of PPARγ
- In 6T mice, fish oil increase bone marrow adiposity, resorption and 
inflammatory markers
- Fish oil effects may dependent on allelic variants in several genes, including 
Pparγ
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Fig 1. 
Effects of 9 months of fish oil diet on body composition, WAT and BAT mass in 6T and B6. 
(A) Total body weight; (B) %fat and (C) %lean evaluated by piximus; (D) WAT ovary mass 
measured at sacrifice per body weight (BW); (E) BAT/BW; (F) WATovary/BAT. * 
p<0.05,** p<0.01 significant difference vs safflower mice. Grey bars,6T; open bars, B6; 
hatched bars, fish oil diet; non-hatched bars, safflower diet. Bars show means (± sem).
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Fig 2. 
Effect of fish oil on BMD, tibial and vertebrae trabecular microarchitecture changes with 
ages in 6T and B6. (A) Total Bone Mineral Density (BMD); (B) femoral BMD; (C) lumbar 
spine BMD; (D) Caudal vertebrae Trabecular bone volume on tissue volume (BV/TV); E) 
Caudal vertebrae trabecular number (TbN); (F) illustration of 3D trabecular structure of the 
vertebrae in mice aged of 12 months; (G) tibial BV/TV; (H) tibial TbN; (I) illustration of 3D 
trabecular structure of the tibia in mice aged of 12 months. * p<0.05 significant difference vs 
safflower mice. Grey bars,6T; open bars, B6; hatched bars, fish oil diet; non-hatched bars, 
safflower diet. Bars show means (± sem).
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Fig 3. 
Effect of fish oil diet on tibial cortical microarchitecture changes with ages in 6T and B6. 
(A) Cortical Tissue Volume (CtTV) at midshaft tibia; (B) Cortical Bone Volume (CtBV); 
(C) Cortical thickness (CtTh); (D) Bone marrow volume (BmV); (E) 2D reconstruction of 
cortical femur midshaft illustrating the lower CtTh in 6T mice under fish oil diet also found 
in femur. * p<0.05, **p<0.01 significant difference vs safflower mice. Grey bars,6T; open 
bars, B6; hatched bars, fish oil diet; non-hatched bars, safflower diet. Bars show means (± 
sem).
Bonnet et al. Page 17
Bone. Author manuscript; available in PMC 2015 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig 4. 
Effect of fish oil diet on femur strength in 6T and B6. Mechanical properties have been 
evaluated by three point bending test. (A) Ultimate (Ul) force; (B) stiffness; (C) yield point; 
(D) elastic energy; € plastic energy; (F) fracture energy. * p<0.05, **p<0.01 significant 
difference vs safflower mice. Grey bars,6T; open bars, B6; hatched bars, fish oil diet; 
nonhatched bars, safflower diet. Bars show means (± sem).
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Fig 5. 
Effect of fish oil diet on osteoclast and bone marrow adiposity in tibia and vertebrae in 6T 
and B6. (A) tibial Osteoclast Surface per Bone surface (OcS/BS); (B) tibial Osteoclast 
Numbers per Tissue Area (OcN/TA); (C) tibial Osteoclast Numbers per Bone Perimeters 
(OcN/BPm); (D) vertebrae OcS/BS; E) vertebrae OcN/TA; (F) vertebrae OcN/BPm; (G) 
histological illustration of increased adipocyte infiltration in tibial bone marrow of 6T under 
fish oil; and absence of adipocyte in bone marrow of vertebrae; (H) Adipocyte volume on 
tissue volume (Adv/TV) in distal femur quantified by microCT after osmium staining; (I) 
3D reconstruction of adipocyte volume present in the marrow space of the all femur.
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